Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Garcés Sterling, Sandra Patricia"'
Autor:
Reina Ávila, María Fernanda, Saza Mejía, Lina María, Guarnizo Zuccardi, Pilar del Rosario, Rengifo, Lyda, Garcés Sterling, Sandra Patricia
Publikováno v:
Revista Colombiana de Reumatología, Volume: 27, Issue: 3, Pages: 190-201, Published: 24 APR 2021
RESUMEN Las alteraciones hematológicas son comunes en los pacientes con lupus eritematoso sistémico (LES). Pueden expresarse relacionadas con el compromiso de las líneas celulares y con la presencia de alteraciones de la coagulación. El compromis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______618::51f6deef5ea9baee8bda36fd2266ca55
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-81232020000300190&lng=en&tlng=en
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-81232020000300190&lng=en&tlng=en
Autor:
Reina Ávila, María Fernanda, Saza Mejía, Lina María, Guarnizo Zuccardi, Pilar del Rosario, Rengifo, Lyda, Garcés Sterling, Sandra Patricia
Publikováno v:
Revista Colombiana de Reumatología; July-September 2020, Vol. 27 Issue: 3 p190-201, 12p
Autor:
Reina Ávila, María Fernanda, Saza Mejía, Lina María, Guarnizo Zuccardi, Pilar del Rosario, Rengifo, Lyda, Garcés Sterling, Sandra Patricia
Publikováno v:
Revista Colombiana de Reumatología (English Edition); July-September 2020, Vol. 27 Issue: 3 p190-201, 12p
Publikováno v:
Masue Imaizumi. Immune and Inherited Thrombocytopenia in Children. Eichi Ischii HD in C, editor. Japón: Springer; 2017. 173, 188 p.
Sanz MÁ, Vicente García V, Fernández A, López MF, Grande C, Jarque I, et al. Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria. Med Clin (Barc). 2012;138(6).
Urturi AF, Salud C De, Valladolid P. Púrpuras. Trombocitopenia inmune primaria. Pediatr Integr. 2012;(5):399–412.
Catherine McGuinn and James B. Bussel. Disorders of Platelets, immune thrombocytopenic purpura (itp). sixth edit. Manual of pediatric hematology and oncology. London: elsevier ltd; 2016. 254-265 p.
Sanz-Alonso M.A VG V. Directrices de diagnóstico, tratamiento y seguimiento de la PTI [Internet]. Vol. 249–1o, Sociedad Española de Pediatría y Hematología. Barcelona. 2011. 49 p
Ramírez LA, Cabrera MP, Arredondo NL. Purpura trombocitopénica autoimmune. 1987;437–42.
Blanchette V, Bolton-Maggs P. Childhood Immune Thrombocytopenic Purpura: Diagnosis and Management. Pediatr Clin North Am. 2008;55(2):393–420.
Tarantino MD, Danese M, Klaassen RJ, Duryea J, Eisen M, Bussel J. Hospitalizations in pediatric patients with immune thrombocytopenia in the United States. Platelets. 2016;27(5):472–8
Stasi R, Newland AC. ITP: A historical perspective. Br J Haematol. 2011;153(4):437–50.
Labarque V, Van Geet C. Clinical practice: Immune thrombocytopenia in paediatrics. Eur J Pediatr. 2014;173(2):163–72.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Donald M, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children. Blood. 2014;113(11):2386–93.
Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther M. American Society of Hematology Clinical guideline update on " Immune thrombocytopenia: an evidence-based practice guideline developed by the American Society of Hematology ". 2011.
Cooper N. State of the art – how I manage immune thrombocytopenia. Br J Haematol. 2017;(March):39–54
Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematology Am Soc Hematol Educ Program. 2006;97–103
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Sanz MÁ, Vicente García V, Fernández A, López MF, Grande C, Jarque I, et al. Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria. Med Clin (Barc). 2012;138(6).
Urturi AF, Salud C De, Valladolid P. Púrpuras. Trombocitopenia inmune primaria. Pediatr Integr. 2012;(5):399–412.
Catherine McGuinn and James B. Bussel. Disorders of Platelets, immune thrombocytopenic purpura (itp). sixth edit. Manual of pediatric hematology and oncology. London: elsevier ltd; 2016. 254-265 p.
Sanz-Alonso M.A VG V. Directrices de diagnóstico, tratamiento y seguimiento de la PTI [Internet]. Vol. 249–1o, Sociedad Española de Pediatría y Hematología. Barcelona. 2011. 49 p
Ramírez LA, Cabrera MP, Arredondo NL. Purpura trombocitopénica autoimmune. 1987;437–42.
Blanchette V, Bolton-Maggs P. Childhood Immune Thrombocytopenic Purpura: Diagnosis and Management. Pediatr Clin North Am. 2008;55(2):393–420.
Tarantino MD, Danese M, Klaassen RJ, Duryea J, Eisen M, Bussel J. Hospitalizations in pediatric patients with immune thrombocytopenia in the United States. Platelets. 2016;27(5):472–8
Stasi R, Newland AC. ITP: A historical perspective. Br J Haematol. 2011;153(4):437–50.
Labarque V, Van Geet C. Clinical practice: Immune thrombocytopenia in paediatrics. Eur J Pediatr. 2014;173(2):163–72.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Donald M, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children. Blood. 2014;113(11):2386–93.
Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther M. American Society of Hematology Clinical guideline update on " Immune thrombocytopenia: an evidence-based practice guideline developed by the American Society of Hematology ". 2011.
Cooper N. State of the art – how I manage immune thrombocytopenia. Br J Haematol. 2017;(March):39–54
Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematology Am Soc Hematol Educ Program. 2006;97–103
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
La trombocitopenia inmune (TI) es una condición que en la gran mayoría de los casos tiene un carácter autoinmune, es necesario diferenciar entre TI primaria y secundaria. En América Latina y especialmente en Colombia no hay estudios recientes sob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1c4dc3bcb0a2228f4dd39edd39b1ca
Publikováno v:
Ludmila E, Neme D, Arbesú G, Dávoli M, Elhelou L, Gastaldo S, et al. Hemofilia. Soc Hematol [Internet]. 2017;12. Available from: http://sah.org.ar/docs/2017/003-Hemofilia.pdf
Bolton-Maggs PHB, Pasi KJ. Haemophilias A and B. Lancet. 2003;361(9371):1801-9.
Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the Management of Hemophilia. Haemophilia. England; 2013 Jan;19(1):e1-47.
World Federation of Hemophilia. World Federation of Hemophilia Report on the Annual Global Survey 2013. World Fed Hemoph. 2012;(December):54.
Acuña Merchan L, Sánchez Quintero P, Soler Voney LA, Al F. Situación de la hemofilia en Colombia 2015. Cuenta Alto Costo Fondo Colombia enfermedades alto costo [Internet]. Bogota; 2015;1-95. Available from: https://cuentadealtocosto.org/site/images/Situacion_de_la_hemofilia_en_Colombia_ 2015.pdf
Rubiano LP, Vanoy LAS, Ñungo LFA, Martínez A, Bogoya AN. Situación de la hemofilia en Colombia. 2016
Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in Hemophilia: Communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935-9.
Departamento de Planeación Nacional. www.sisben.gov.co [Internet]. [cited 2018 Nov 23]. Available from: https://www.sisben.gov.co/sisben/paginas/que-es.aspx
García-Chávez J, Majluf-Cruz A. Hemofilia. Gac Med Mex. 2013;149:308-21.
Castillo-González D. Hemofilia: aspectos históricos y genéticos. Rev Cuba Hematol Inmunol y Hemoter [Internet]. 2000, Editorial Ciencias Médicas; [cited 2016 Nov 1];28(1):22-33. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892012000100003&lng=es&nrm =iso&tlng=es
Carcao M. The Diagnosis and Management of Congenital Hemophilia. Semin Thromb Hemost [Internet]. 2012;38(07):727–34. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s0032-1326786
World Federation of Hemophilia (WHF). Report of the Annual Global Survey 2016. World Federation Hemoph [Internet]. 2017;514(October):3-73. Available from: www.wfh.org
Soucie JM, Evatt B, Jackson D. Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators. Am J Hematol. 1998;59(4):288–94.
Acuña L. Boletín de información técnica especializada de la Cuenta de Alto Costo Volumen 4, número 01 [Internet]. Cuenta de Alto Costo. 2018. Available from: https://cuentadealtocosto.org/site /images/Publicaciones/2018/Boletin_17_Abril_Dia_mundial_de_la_hemofilia_2018.pdf
García-Chávez J, Majluf-Cruz A. Hemofilia. 2013;149.
Guzmán Freja A, Siado TI. Hemofilia tipo B en mujeres. Reporte de dos casos Type b Haemophilia in Women. Reports of Two Cases. 2013
Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, et al. Haemophilia B: Database of Point Mutations and Short Additions and Deletions-Eighth edition. Nucleic Acids Res. 1998;26(1):265-8.
Franchini M, Mannucci PM. Hemophilia A in the Third Millennium. Blood Rev [Internet]. Elsevier Ltd; 2013;27(4):179-84. Available from: http://dx.doi.org/10.1016/j.blre.2013.06.002
J. BC, Melvin S, D. RO. Airway Obstruction in Hemophilia (factor VIII Deficiency): A 28-Year Institutional Review. Laryngoscope [Internet]. 2009;104(7):789-94. Available from: https://doi.org/10.1288/00005537-199407000-00002
E. MH, S. KC. Small Bowel Hematoma in a Hemophiliac as a Cause of Pseudoappendicitis: Diagnosis by ct Imaging. Am J Hematol [Internet]. 2006;38(2):138-9. Available from: https://doi.org/10.1002/ajh.2830380212
Small S, Rose PE, McMillan N, Belch JJ, Rolfe EB, Forbes CD, et al. Haemophilia and the Kidney: Assessment after 11-Year Follow-Up. BMJ [Internet]. BMJ Publishing Group Ltd; 1982;285(6355):1609–11. Available from: https://www.bmj.com/content/285/6355/1609
Alhaosawi M. Guidelines of Management of Musculoskeletal Complications of Hemophilia. J Appl Hematol [Internet]. 2014 Jul 1;5(3):75-85. Available from: http://www.jahjournal.org/article.asp?issn=1658-5127
Avina-Zubieta JA, Galindo-Rodriguez G, Lavalle C. Rheumatic Manifestations of Hematologic Disorders. Curr Opin Rheumatol. United States; 1998 Jan;10(1):86-90
Aledort LM, Haschmeyer RH, Pettersson H. A Longitudinal Study of Orthopaedic Outcomes for Severe Factor VIII Deficient Haemophiliacs. J Intern Med. 1994;236:391-9
Jansen NWD, Roosendaal G, Lafeber FPJG. Understanding Haemophilic Arthropathy: an Exploration of Current Open Issues. Br J Haematol. 2008;143(5):632-40
Rauch A, Paris C. Hemostasia primaria. EMC-Tratado Med [Internet]. 2018;22(1):1-12. Available from: https://www.sciencedirect.com/science/article/pii/S1636541017878661
Cervera Bravo A, Álvarez Román MT. Fisiopatología y trastornos de la coagulación hereditarios más frecuentes. Pediatr Integr. 2016
Favaloro EJ, Meijer P, Jennings I, Sioufi J, Bonar RA, Kitchen DP, et al. Problems and Solutions in Laboratory Testing for Hemophilia. Semin Thromb Hemost. 2014;40(1):135
Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, et al. Factor VIII Inhibitors in Mild and Moderate-Severity Haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost. Germany; 1998 Apr;79(4):762-6.
Enayat MS, Guilliatt AM, Lester W, Wilde JT, Williams MD, Hill FGH. Distinguishing Between Type 2B and Pseudo-Von Willebrand Disease and its Clinical Importance. Br J Haematol. 2006;133(6):6646.
Bolton-Maggs PHB, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, et al. A Review of Inherited Platelet Disorders with Guidelines for their Management on Behalf of the UKHCDO. Br J Haematol. 2006;135(5):603-33.
Podmore a, Smith M, Savidge G, Alhaq a. Real-time Quantitative PCR Analysis of Factor XI Mrna Variants in Human Platelets. J Thromb Haemost [Internet]. 2004;2(10):1713–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15456480
Eshghi P, Abolghasemi H, Sanei-Moghaddam H, Anwar R, Jazebi M, Amid A, et al. Factor XIII Deficiency in South-East Iran. Haemophilia. 2004;10(5):470-2.
Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare Coagulation Deficiencies. Haemophilia. England; 2002 May;8(3):308-21
Donfield SM, Lynn HS, Lail AE, Hoots WK, Berntorp E, Gomperts ED. Delays in Maturation Among Adolescents with Hemophilia and a History of Inhibitors. Blood. 2007;110(10):3656-61.
White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in Hemophilia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. Germany; 2001 Mar;85(3):560.
Caram C, de Souza RG, de Sousa JC, Araujo Pereira T, do Amaral Cerqueira AM, van der Bom JG, et al. The Long-Term Course of Factor VIII Inhibitors in Patients with Congenital Haemophilia a without Immune Tolerance Induction. Thromb Haemost. Germany; 2011 Jan;105(1):59-65.
Kempton CL, Ii GCW. How We Treat a Hemophilia a Patient with a Factor VIII Inhibitor How I Treat How We Treat a Hemophilia a Patient with a Factor VIII Inhibitor. 2014;113(1):11-7.
Bolton-Maggs PHB. Optimal Haemophilia Care versus the Reality. Br J Haematol. England; 2006 Mar;132(6):671-82.
Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H, et al. Mortality Among Males with Hemophilia: Relations with Source Of Medical Care. The Hemophilia Surveillance System Project Investigators. Blood. United States; 2000 Jul;96(2):437-42.
Oldenburg J. Optimal Treatment Strategies for Hemophilia: Achievements and Limitations of Current Prophylactic Regimens. Blood. 2015;125(13):2038-44.
Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, et al. Intracranial Haemorrhage in Children and Adolescents with Severe Haemophilia A or B. The Impact of Prophylactic Treatment. Br J Haematol. 2017;179(2):298-307.
Ljung R. The Risk Associated with Indwelling Catheters in Children with Haemophilia. Br J Haematol. 2007;138(5):580-6.
Richards M, Williams M, Chalmers E, Liesner R, Collins P, Vidler V, et al. A United Kingdom Haemophilia Centre Doctors’ Organization Guideline Approved by the British Committee for Standards in Haematology: Guideline on the Use of Prophylactic Factor VIII Concentrate In Children and Adults with Severe Haemophilia A. Br J Haematol. England; 2010 May;149(4):498-507.
Peyvandi F, Garagiola I, Young G. The Past and Future of Haemophilia: Diagnosis, Treatments, and its Complications. Lancet [Internet]. Elsevier Ltd; 2016;388(10040):187-97. Available from: http://dx.doi.org/10.1016/S0140-6736(15)01123-X
Mei B, Pan C, Jiang H, Tjandra H, Strauss J, Chen Y, et al. Rational Design of a Fully Active, LongActing Pegylated Factor VIII for Hemophilia a Treatment. Blood. 2010;116(2):270-9.
Chowdary P, Lethagen S, Friedrich U, Brand B, Hay C, Abdul Karim F, et al. Safety and Pharmacokinetics of Anti-TFPI Antibody (Concizumab) in Healthy Volunteers and Patients with Hemophilia: a Randomized First Human Dose Trial. J Thromb Haemost. 2015;13(5):743-54
World Medical Asociation (AMM). Declaración de Helsinki de la AMM-Principios éticos para las investigaciones médicas en seres humanos. World Med Assoc Inc [Internet]. 2013;1-8. Available from: http://www.wma.net/es/30publications/10policies/b3/
Ministerio de Salud. Resolución 8430 de 1993. Ministerio de Salud y Protección Social República de Colombia. 1993;1993(Octubre 4):1-19
Rodríguez-Merchan EC. Musculoskeletal Complications of Hemophilia. HSS J. 2010;6(1):37-42.
Chang CY, Li TY, Cheng SN, Pan RY, Wang HJ, Lin SY, et al. Prevalence and Severity by Age and other Clinical Correlates of Haemophilic Arthropathy of the Elbow, Knee and Ankle Among Taiwanese Patients with Haemophilia. Haemophilia. 2017;23(2):284-91.
Knobe K, Berntorp E. Haemophilia and Joint Disease: Pathophysiology, Evaluation, and Management. J Comorbidity. 2011;11:51-5951.
Carpenter SL, Michael Soucie J, Sterner S, Presley R. Increased Prevalence of Inhibitors in Hispanic Patients with Severe Haemophilia a Enrolled in the Universal Data Collection Database. Haemophilia. 2012;18(3):1-6.
Oliveira M, Duarte E. Guidelines for the Management of Hemophilia. Haemophilia. 2012;(20).
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Bolton-Maggs PHB, Pasi KJ. Haemophilias A and B. Lancet. 2003;361(9371):1801-9.
Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the Management of Hemophilia. Haemophilia. England; 2013 Jan;19(1):e1-47.
World Federation of Hemophilia. World Federation of Hemophilia Report on the Annual Global Survey 2013. World Fed Hemoph. 2012;(December):54.
Acuña Merchan L, Sánchez Quintero P, Soler Voney LA, Al F. Situación de la hemofilia en Colombia 2015. Cuenta Alto Costo Fondo Colombia enfermedades alto costo [Internet]. Bogota; 2015;1-95. Available from: https://cuentadealtocosto.org/site/images/Situacion_de_la_hemofilia_en_Colombia_ 2015.pdf
Rubiano LP, Vanoy LAS, Ñungo LFA, Martínez A, Bogoya AN. Situación de la hemofilia en Colombia. 2016
Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in Hemophilia: Communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935-9.
Departamento de Planeación Nacional. www.sisben.gov.co [Internet]. [cited 2018 Nov 23]. Available from: https://www.sisben.gov.co/sisben/paginas/que-es.aspx
García-Chávez J, Majluf-Cruz A. Hemofilia. Gac Med Mex. 2013;149:308-21.
Castillo-González D. Hemofilia: aspectos históricos y genéticos. Rev Cuba Hematol Inmunol y Hemoter [Internet]. 2000, Editorial Ciencias Médicas; [cited 2016 Nov 1];28(1):22-33. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892012000100003&lng=es&nrm =iso&tlng=es
Carcao M. The Diagnosis and Management of Congenital Hemophilia. Semin Thromb Hemost [Internet]. 2012;38(07):727–34. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s0032-1326786
World Federation of Hemophilia (WHF). Report of the Annual Global Survey 2016. World Federation Hemoph [Internet]. 2017;514(October):3-73. Available from: www.wfh.org
Soucie JM, Evatt B, Jackson D. Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators. Am J Hematol. 1998;59(4):288–94.
Acuña L. Boletín de información técnica especializada de la Cuenta de Alto Costo Volumen 4, número 01 [Internet]. Cuenta de Alto Costo. 2018. Available from: https://cuentadealtocosto.org/site /images/Publicaciones/2018/Boletin_17_Abril_Dia_mundial_de_la_hemofilia_2018.pdf
García-Chávez J, Majluf-Cruz A. Hemofilia. 2013;149.
Guzmán Freja A, Siado TI. Hemofilia tipo B en mujeres. Reporte de dos casos Type b Haemophilia in Women. Reports of Two Cases. 2013
Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, et al. Haemophilia B: Database of Point Mutations and Short Additions and Deletions-Eighth edition. Nucleic Acids Res. 1998;26(1):265-8.
Franchini M, Mannucci PM. Hemophilia A in the Third Millennium. Blood Rev [Internet]. Elsevier Ltd; 2013;27(4):179-84. Available from: http://dx.doi.org/10.1016/j.blre.2013.06.002
J. BC, Melvin S, D. RO. Airway Obstruction in Hemophilia (factor VIII Deficiency): A 28-Year Institutional Review. Laryngoscope [Internet]. 2009;104(7):789-94. Available from: https://doi.org/10.1288/00005537-199407000-00002
E. MH, S. KC. Small Bowel Hematoma in a Hemophiliac as a Cause of Pseudoappendicitis: Diagnosis by ct Imaging. Am J Hematol [Internet]. 2006;38(2):138-9. Available from: https://doi.org/10.1002/ajh.2830380212
Small S, Rose PE, McMillan N, Belch JJ, Rolfe EB, Forbes CD, et al. Haemophilia and the Kidney: Assessment after 11-Year Follow-Up. BMJ [Internet]. BMJ Publishing Group Ltd; 1982;285(6355):1609–11. Available from: https://www.bmj.com/content/285/6355/1609
Alhaosawi M. Guidelines of Management of Musculoskeletal Complications of Hemophilia. J Appl Hematol [Internet]. 2014 Jul 1;5(3):75-85. Available from: http://www.jahjournal.org/article.asp?issn=1658-5127
Avina-Zubieta JA, Galindo-Rodriguez G, Lavalle C. Rheumatic Manifestations of Hematologic Disorders. Curr Opin Rheumatol. United States; 1998 Jan;10(1):86-90
Aledort LM, Haschmeyer RH, Pettersson H. A Longitudinal Study of Orthopaedic Outcomes for Severe Factor VIII Deficient Haemophiliacs. J Intern Med. 1994;236:391-9
Jansen NWD, Roosendaal G, Lafeber FPJG. Understanding Haemophilic Arthropathy: an Exploration of Current Open Issues. Br J Haematol. 2008;143(5):632-40
Rauch A, Paris C. Hemostasia primaria. EMC-Tratado Med [Internet]. 2018;22(1):1-12. Available from: https://www.sciencedirect.com/science/article/pii/S1636541017878661
Cervera Bravo A, Álvarez Román MT. Fisiopatología y trastornos de la coagulación hereditarios más frecuentes. Pediatr Integr. 2016
Favaloro EJ, Meijer P, Jennings I, Sioufi J, Bonar RA, Kitchen DP, et al. Problems and Solutions in Laboratory Testing for Hemophilia. Semin Thromb Hemost. 2014;40(1):135
Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, et al. Factor VIII Inhibitors in Mild and Moderate-Severity Haemophilia A. UK Haemophilia Centre Directors Organisation. Thromb Haemost. Germany; 1998 Apr;79(4):762-6.
Enayat MS, Guilliatt AM, Lester W, Wilde JT, Williams MD, Hill FGH. Distinguishing Between Type 2B and Pseudo-Von Willebrand Disease and its Clinical Importance. Br J Haematol. 2006;133(6):6646.
Bolton-Maggs PHB, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, et al. A Review of Inherited Platelet Disorders with Guidelines for their Management on Behalf of the UKHCDO. Br J Haematol. 2006;135(5):603-33.
Podmore a, Smith M, Savidge G, Alhaq a. Real-time Quantitative PCR Analysis of Factor XI Mrna Variants in Human Platelets. J Thromb Haemost [Internet]. 2004;2(10):1713–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15456480
Eshghi P, Abolghasemi H, Sanei-Moghaddam H, Anwar R, Jazebi M, Amid A, et al. Factor XIII Deficiency in South-East Iran. Haemophilia. 2004;10(5):470-2.
Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare Coagulation Deficiencies. Haemophilia. England; 2002 May;8(3):308-21
Donfield SM, Lynn HS, Lail AE, Hoots WK, Berntorp E, Gomperts ED. Delays in Maturation Among Adolescents with Hemophilia and a History of Inhibitors. Blood. 2007;110(10):3656-61.
White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in Hemophilia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. Germany; 2001 Mar;85(3):560.
Caram C, de Souza RG, de Sousa JC, Araujo Pereira T, do Amaral Cerqueira AM, van der Bom JG, et al. The Long-Term Course of Factor VIII Inhibitors in Patients with Congenital Haemophilia a without Immune Tolerance Induction. Thromb Haemost. Germany; 2011 Jan;105(1):59-65.
Kempton CL, Ii GCW. How We Treat a Hemophilia a Patient with a Factor VIII Inhibitor How I Treat How We Treat a Hemophilia a Patient with a Factor VIII Inhibitor. 2014;113(1):11-7.
Bolton-Maggs PHB. Optimal Haemophilia Care versus the Reality. Br J Haematol. England; 2006 Mar;132(6):671-82.
Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H, et al. Mortality Among Males with Hemophilia: Relations with Source Of Medical Care. The Hemophilia Surveillance System Project Investigators. Blood. United States; 2000 Jul;96(2):437-42.
Oldenburg J. Optimal Treatment Strategies for Hemophilia: Achievements and Limitations of Current Prophylactic Regimens. Blood. 2015;125(13):2038-44.
Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, et al. Intracranial Haemorrhage in Children and Adolescents with Severe Haemophilia A or B. The Impact of Prophylactic Treatment. Br J Haematol. 2017;179(2):298-307.
Ljung R. The Risk Associated with Indwelling Catheters in Children with Haemophilia. Br J Haematol. 2007;138(5):580-6.
Richards M, Williams M, Chalmers E, Liesner R, Collins P, Vidler V, et al. A United Kingdom Haemophilia Centre Doctors’ Organization Guideline Approved by the British Committee for Standards in Haematology: Guideline on the Use of Prophylactic Factor VIII Concentrate In Children and Adults with Severe Haemophilia A. Br J Haematol. England; 2010 May;149(4):498-507.
Peyvandi F, Garagiola I, Young G. The Past and Future of Haemophilia: Diagnosis, Treatments, and its Complications. Lancet [Internet]. Elsevier Ltd; 2016;388(10040):187-97. Available from: http://dx.doi.org/10.1016/S0140-6736(15)01123-X
Mei B, Pan C, Jiang H, Tjandra H, Strauss J, Chen Y, et al. Rational Design of a Fully Active, LongActing Pegylated Factor VIII for Hemophilia a Treatment. Blood. 2010;116(2):270-9.
Chowdary P, Lethagen S, Friedrich U, Brand B, Hay C, Abdul Karim F, et al. Safety and Pharmacokinetics of Anti-TFPI Antibody (Concizumab) in Healthy Volunteers and Patients with Hemophilia: a Randomized First Human Dose Trial. J Thromb Haemost. 2015;13(5):743-54
World Medical Asociation (AMM). Declaración de Helsinki de la AMM-Principios éticos para las investigaciones médicas en seres humanos. World Med Assoc Inc [Internet]. 2013;1-8. Available from: http://www.wma.net/es/30publications/10policies/b3/
Ministerio de Salud. Resolución 8430 de 1993. Ministerio de Salud y Protección Social República de Colombia. 1993;1993(Octubre 4):1-19
Rodríguez-Merchan EC. Musculoskeletal Complications of Hemophilia. HSS J. 2010;6(1):37-42.
Chang CY, Li TY, Cheng SN, Pan RY, Wang HJ, Lin SY, et al. Prevalence and Severity by Age and other Clinical Correlates of Haemophilic Arthropathy of the Elbow, Knee and Ankle Among Taiwanese Patients with Haemophilia. Haemophilia. 2017;23(2):284-91.
Knobe K, Berntorp E. Haemophilia and Joint Disease: Pathophysiology, Evaluation, and Management. J Comorbidity. 2011;11:51-5951.
Carpenter SL, Michael Soucie J, Sterner S, Presley R. Increased Prevalence of Inhibitors in Hispanic Patients with Severe Haemophilia a Enrolled in the Universal Data Collection Database. Haemophilia. 2012;18(3):1-6.
Oliveira M, Duarte E. Guidelines for the Management of Hemophilia. Haemophilia. 2012;(20).
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción De acuerdo con la Cuenta de Alto Costo para el 2015, en Colombia, 1838 pacientes tenían diagnóstico de hemofilia, de los cuales 776 fueron pediátricos (42%). La hemartrosis es la principal complicación en estos pacientes, ya que ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b2598058da0534b930611ed8ca5962
Publikováno v:
Spentzouris G, Scriven RJ, Lee TK, Labropoulos N. Pediatric venous thromboembolism in relation to adults. J Vasc Surg. 2012;55(6):1785-93
Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg. 2008;47(4):837-43
Boulet SL, Grosse SD, Thornburg CD, Yusuf H, Tsai J, Hooper WC. Trends in venous thromboembolism-related hospitalizations, 1994-2009. Pediatrics. 2012;130(4):e812-20
Chan AK, Monagle P. Updates in thrombosis in pediatrics: where are we after 20 years? Hematology Am Soc Hematol Educ Program. 2012;2012:439-43
Tolbert J, Carpenter SL. Common acquired causes of thrombosis in children. Curr Probl Pediatr Adolesc Health Care. 2013;43(7):169-77
Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001-8
Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83(5):1251-7
Nowak-Göttl U, Janssen V, Manner D, Kenet G. Venous thromboembolism in neonates and children--update 2013. Thromb Res. 2013;131 Suppl 1:S39-41
Samková A, Lejhancová K, Hak J, Lukes A. Venous thromboembolism in adolescents. Acta Medica (Hradec Kralove). 2012;55(2):78-82
Kenet G, Nowak-Göttl U. Venous thromboembolism in neonates and children. Best Pract Res Clin Haematol. 2012;25(3):333-44
Chalmers EA. Epidemiology of venous thromboembolism in neonates and children. Thromb Res. 2006;118(1):3-12
Wright JM, Watts RG. Venous thromboembolism in pediatric patients: epidemiologic data from a pediatric tertiary care center in Alabama. J Pediatr Hematol Oncol. 2011;33(4):261-4
Massicotte MP, Sofronas M, deVeber G. Difficulties in performing clinical trials of antithrombotic therapy in neonates and children. Thromb Res. 2006;118(1):153-63
Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg. 2012;114(2):275-85
Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938-49
Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis. 2003;16(1-2):17-20
Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S. Models of blood coagulation. Blood Cells Mol Dis. 2006;36(2):108-17
Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev. 2003;17 Suppl 1:S1-5
Butenas S, Orfeo T, Mann KG. Tissue factor activity and function in blood coagulation. Thromb Res. 2008;122 Suppl 1:S42-6
Roth M, Manwani D. Thrombotic disorders. Pediatr Rev. 2011;32(1):41-3
Revel-Vilk S, Kenet G. Thrombophilia in children with venous thromboembolic disease. Thromb Res. 2006;118(1):59-65
Zöller B, García de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologica. 1999;84(1):59-70
Raffini L, Thornburg C. Testing children for inherited thrombophilia: more questions than answers. Br J Haematol. 2009;147(3):277-88
Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost. 2003;1(5):915-21
Journeycake JM, Buchanan GR. Coagulation disorders. Pediatr Rev. 2003;24(3):83-91
Goldenberg NA. Thrombophilia states and markers of coagulation activation in the prediction of pediatric venous thromboembolic outcomes: a comparative analysis with respect to adult evidence. Hematology Am Soc Hematol Educ Program. 2008:236-44
Brandao LR, Segel GB. Question from the clinician: risk of thrombophilia. Pediatr Rev. 2012;33(7):321-2
Takemoto CM, Sohi S, Desai K, Bharaj R, Khanna A, McFarland S, et al. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. J Pediatr. 2014;164(2):332-8
Hanslik A, Thom K, Haumer M, Kitzmüller E, Albinni S, Wolfsberger M, et al. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system. Pediatrics. 2008;122(6):1284-91
Kanin M, Young G. Incidence of thrombosis in children with tunneled central venous access devices versus peripherally inserted central catheters (PICCs). Thromb Res. 2013;132(5):527-30
Piovesan D, Attard C, Monagle P, Ignjatovic V. Epidemiology of venous thrombosis in children with cancer. Thromb Haemost. 2014;111(6):1015-21
Falanga A, Marchetti M. Anticancer treatment and thrombosis. Thromb Res. 2012;129(3):353-9
De Stefano V, Za T, Ciminello A, Betti S, Rossi E. Haemostatic alterations induced by treatment with asparaginases and clinical consequences. Thromb Haemost. 2014;113(2)
Kim SJ, Sabharwal S. Risk factors for venous thromboembolism in hospitalized children and adolescents: a systemic review and pooled analysis. J Pediatr Orthop B. 2014;23(4):389-93
Stokes S, Breheny P, Radulescu A, Radulescu VC. Impact of obesity on the risk of venous thromboembolism in an inpatient pediatric population. Pediatr Hematol Oncol. 2014;31(5):475-80
Branchford BR, Mourani P, Bajaj L, Manco-Johnson M, Wang M, Goldenberg NA. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012;97(4):509-15
Sharathkumar AA, Mahajerin A, Heidt L, Doerfer K, Heiny M, Vik T, et al. Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule. J Thromb Haemost. 2012;10(7):1326-34
Atchison CM, Arlikar S, Amankwah E, Ayala I, Barrett L, Branchford BR, et al. Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study. J Pediatr. 2014;165(4):793-8
Yang JY, Chan AK. Pediatric thrombophilia. Pediatr Clin North Am. 2013;60(6):1443-62
Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e737S-801S
Faustino EV, Spinella PC, Li S, Pinto MG, Stoltz P, Tala J, et al. Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children. J Pediatr. 2013;162(2):387-91
Li S, Sun X, Wang Z. Observation of short-term catheter induced thrombosis in children treated with blood purification. Hippokratia. 2014; 18 (3): 245-50
Sol JJ, Knoester H, de Neef M, Smets AM, Betlem A, van Ommen CH. Chronic Complications After Femoral Central Venous Catheter-related Thrombosis in Critically Ill Children. J Pediatr Hematol Oncol 2015; 37 (6): 462-7
Jumani K, Advani S, Reich NG, Gosey L, Milstone AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr. 2013; 167 (5): 429-35
Smitherman AB, Alexander T, Connelly M, Snavely AC, Weston BW, Liles EA, Steiner MJ. The incidence of catheter-associated venous thrombosis in noncritically ill children. Hosp Pediatr. 2015; 5 (2): 59-66
Reiter PD, Wathen B, Valuck RJ, Dobyns EL. Pediatr Crit Care Med 2012; 13 (4): 381-6
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg. 2008;47(4):837-43
Boulet SL, Grosse SD, Thornburg CD, Yusuf H, Tsai J, Hooper WC. Trends in venous thromboembolism-related hospitalizations, 1994-2009. Pediatrics. 2012;130(4):e812-20
Chan AK, Monagle P. Updates in thrombosis in pediatrics: where are we after 20 years? Hematology Am Soc Hematol Educ Program. 2012;2012:439-43
Tolbert J, Carpenter SL. Common acquired causes of thrombosis in children. Curr Probl Pediatr Adolesc Health Care. 2013;43(7):169-77
Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001-8
Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83(5):1251-7
Nowak-Göttl U, Janssen V, Manner D, Kenet G. Venous thromboembolism in neonates and children--update 2013. Thromb Res. 2013;131 Suppl 1:S39-41
Samková A, Lejhancová K, Hak J, Lukes A. Venous thromboembolism in adolescents. Acta Medica (Hradec Kralove). 2012;55(2):78-82
Kenet G, Nowak-Göttl U. Venous thromboembolism in neonates and children. Best Pract Res Clin Haematol. 2012;25(3):333-44
Chalmers EA. Epidemiology of venous thromboembolism in neonates and children. Thromb Res. 2006;118(1):3-12
Wright JM, Watts RG. Venous thromboembolism in pediatric patients: epidemiologic data from a pediatric tertiary care center in Alabama. J Pediatr Hematol Oncol. 2011;33(4):261-4
Massicotte MP, Sofronas M, deVeber G. Difficulties in performing clinical trials of antithrombotic therapy in neonates and children. Thromb Res. 2006;118(1):153-63
Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg. 2012;114(2):275-85
Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938-49
Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis. 2003;16(1-2):17-20
Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S. Models of blood coagulation. Blood Cells Mol Dis. 2006;36(2):108-17
Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev. 2003;17 Suppl 1:S1-5
Butenas S, Orfeo T, Mann KG. Tissue factor activity and function in blood coagulation. Thromb Res. 2008;122 Suppl 1:S42-6
Roth M, Manwani D. Thrombotic disorders. Pediatr Rev. 2011;32(1):41-3
Revel-Vilk S, Kenet G. Thrombophilia in children with venous thromboembolic disease. Thromb Res. 2006;118(1):59-65
Zöller B, García de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologica. 1999;84(1):59-70
Raffini L, Thornburg C. Testing children for inherited thrombophilia: more questions than answers. Br J Haematol. 2009;147(3):277-88
Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost. 2003;1(5):915-21
Journeycake JM, Buchanan GR. Coagulation disorders. Pediatr Rev. 2003;24(3):83-91
Goldenberg NA. Thrombophilia states and markers of coagulation activation in the prediction of pediatric venous thromboembolic outcomes: a comparative analysis with respect to adult evidence. Hematology Am Soc Hematol Educ Program. 2008:236-44
Brandao LR, Segel GB. Question from the clinician: risk of thrombophilia. Pediatr Rev. 2012;33(7):321-2
Takemoto CM, Sohi S, Desai K, Bharaj R, Khanna A, McFarland S, et al. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. J Pediatr. 2014;164(2):332-8
Hanslik A, Thom K, Haumer M, Kitzmüller E, Albinni S, Wolfsberger M, et al. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system. Pediatrics. 2008;122(6):1284-91
Kanin M, Young G. Incidence of thrombosis in children with tunneled central venous access devices versus peripherally inserted central catheters (PICCs). Thromb Res. 2013;132(5):527-30
Piovesan D, Attard C, Monagle P, Ignjatovic V. Epidemiology of venous thrombosis in children with cancer. Thromb Haemost. 2014;111(6):1015-21
Falanga A, Marchetti M. Anticancer treatment and thrombosis. Thromb Res. 2012;129(3):353-9
De Stefano V, Za T, Ciminello A, Betti S, Rossi E. Haemostatic alterations induced by treatment with asparaginases and clinical consequences. Thromb Haemost. 2014;113(2)
Kim SJ, Sabharwal S. Risk factors for venous thromboembolism in hospitalized children and adolescents: a systemic review and pooled analysis. J Pediatr Orthop B. 2014;23(4):389-93
Stokes S, Breheny P, Radulescu A, Radulescu VC. Impact of obesity on the risk of venous thromboembolism in an inpatient pediatric population. Pediatr Hematol Oncol. 2014;31(5):475-80
Branchford BR, Mourani P, Bajaj L, Manco-Johnson M, Wang M, Goldenberg NA. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012;97(4):509-15
Sharathkumar AA, Mahajerin A, Heidt L, Doerfer K, Heiny M, Vik T, et al. Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule. J Thromb Haemost. 2012;10(7):1326-34
Atchison CM, Arlikar S, Amankwah E, Ayala I, Barrett L, Branchford BR, et al. Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study. J Pediatr. 2014;165(4):793-8
Yang JY, Chan AK. Pediatric thrombophilia. Pediatr Clin North Am. 2013;60(6):1443-62
Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e737S-801S
Faustino EV, Spinella PC, Li S, Pinto MG, Stoltz P, Tala J, et al. Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children. J Pediatr. 2013;162(2):387-91
Li S, Sun X, Wang Z. Observation of short-term catheter induced thrombosis in children treated with blood purification. Hippokratia. 2014; 18 (3): 245-50
Sol JJ, Knoester H, de Neef M, Smets AM, Betlem A, van Ommen CH. Chronic Complications After Femoral Central Venous Catheter-related Thrombosis in Critically Ill Children. J Pediatr Hematol Oncol 2015; 37 (6): 462-7
Jumani K, Advani S, Reich NG, Gosey L, Milstone AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr. 2013; 167 (5): 429-35
Smitherman AB, Alexander T, Connelly M, Snavely AC, Weston BW, Liles EA, Steiner MJ. The incidence of catheter-associated venous thrombosis in noncritically ill children. Hosp Pediatr. 2015; 5 (2): 59-66
Reiter PD, Wathen B, Valuck RJ, Dobyns EL. Pediatr Crit Care Med 2012; 13 (4): 381-6
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
La trombosis relacionada al uso del catéter es un problema que cobra cada vez mayor importancia. Se han descrito factores de riesgo para su presentación en la población pediátrica pero aún no se han realizado estudios en nuestro medio. Objetivo:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ecc6e3436412b0515409aee1c13fa95
http://repository.urosario.edu.co/handle/10336/11780
http://repository.urosario.edu.co/handle/10336/11780
Publikováno v:
ANTUNES, S. V., TANGADA, S., STASYSHYN, O., MAMONOV, V., PHILLIPS, J., GUZMAN-BECERRA, N., GRIGORIAN, A., EWENSTEIN, B. AND WONG, W.-Y. Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors. Haemophilia, (2014), 20: 65–72. doi: 10.1111/hae.12246
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
La hemofilia A y B son trastornos hereditarios recesivos ligados al cromosoma X y se caracterizan por la deficiencia de los factores de coagulación VIII y IX, respectivamente. La complicación más importante , durante el tratamiento, es el desarrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eda1fa751df29e57bfac62440424a4b